Cargando…
Pancreatic cancer triggers diabetes through TGF-β–mediated selective depletion of islet β-cells
Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease that remains incurable because of late diagnosis, which renders any therapeutic intervention challenging. Most PDAC patients develop de novo diabetes, which exacerbates their morbidity and mortality. How PDAC triggers diabetes is still unfo...
Autores principales: | Parajuli, Parash, Nguyen, Thien Ly, Prunier, Céline, Razzaque, Mohammed S, Xu, Keli, Atfi, Azeddine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Life Science Alliance LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211975/ https://www.ncbi.nlm.nih.gov/pubmed/32371554 http://dx.doi.org/10.26508/lsa.201900573 |
Ejemplares similares
-
NF1 loss of function as an alternative initiating event in pancreatic ductal adenocarcinoma
por: Ramakrishnan, Gopalakrishnan, et al.
Publicado: (2022) -
Antagonism between Prdm16 and Smad4 specifies the trajectory and progression of pancreatic cancer
por: Hurwitz, Eric, et al.
Publicado: (2023) -
TGIF1-Twist1 axis in pancreatic ductal adenocarcinoma
por: Razzaque, Mohammed S., et al.
Publicado: (2020) -
The disintegrin and metalloproteinase ADAM12 contributes to TGF-β signaling through interaction with the type II receptor
por: Atfi, Azeddine, et al.
Publicado: (2007) -
Regulatory Role of the Transcription Factor Twist1 in Cancer-Associated Muscle Cachexia
por: Razzaque, Mohammed S., et al.
Publicado: (2020)